ATLANTA and SCHAUMBURG, Ill., June 23 /PRNewswire/ -- Consorta, Inc., a leading health care group purchasing organization, signed an agreement with Elekta for radiation oncology solutions for its member hospital and clinic groups. Elekta was also chosen by Consorta as their provider for stereotactic radiosurgery solutions.
(Logo: http://www.newscom.com/cgi-bin/prnh/20020318/ELEKTALOGO )
"Industry leading technology is very important to Consorta members and one of the many reasons we have chosen Elekta as one of our suppliers of radiation oncology equipment," said Dan Ingram, manager of imaging contracting for Consorta.
Elekta was awarded the contract through Consorta's intensive vendor selection process, which focuses on delivering high-quality, cost-effective products and services to Consorta's health care provider customers. Consorta's membership includes more than 400 acute care facilities representing 55,000 beds, and more than 1,700 non-acute care sites.
The contract for Elekta's oncology product lines encompasses the company's complete Digital Delivery Systems product line of Linear Accelerators, advanced X-Ray Volume Imaging systems, exclusive Elekta accessories and options, and Radiation Treatment Planning systems. Elekta's most recently announced products for Image-Guided Radiation Therapy (IGRT) are a major part of the agreement.
The contract also covers Elekta's ground breaking IGRT platform, Elekta Synergy(TM) -- the first radiation treatment machine with an integrated imaging system. This technology will enable doctors to obtain images of patients just before their treatment, allowing them to visualize tumors at the point of treatment, to more precisely target tumors with radiation beams. In addition, Consorta members will have access to Elekta Synergy(TM) S (currently a works in progress), the extracranial stereotactic version of Elekta Synergy(TM), featuring a precision Beam Modulator System, which will provide fine resolution beam-shaping.
Elekta received regulatory approval for the Elekta Synergy(TM) platform in 2003. The company was the first manufacturer to start research on IGRT, the first to have systems in clinical use, and the first to bring these solutions to market. Elekta Synergy(TM) is the most advanced image-guided radiotherapy (IGRT) solution available today.
"This contract validates the reason we are the world's fastest growing supplier of radiation oncology solutions for precision radiotherapy," said Peter J. Gaccione, Vice President, Oncology at Elekta. "Elekta's cutting edge solutions combined with an unmatched depth of experience and commitment to service will give Consorta's members a real advantage in the increasingly competitive health care marketplace."
Elekta's state-of-the-art treatment solutions are highly effective and offer proven clinical outcomes providing a foundation for long-term success, generating a strong return on investment for treatment centers. Additionally, Elekta's on-going education programs, users groups and research, combined with comprehensive business support programs, have created a role model for the industry. By combining quality patient care with business success, Elekta has created a solution that is suitable for any size facility.
About Consorta:
Consorta, Inc. is a leading health care resource management and group purchasing organization, whose shareholders are faith based or non-profit health systems. As a cooperative, Consorta's shareholders and participants share fully in the organization's bottom-line performance and receive discounts on product purchases through scale purchasing economies. Consorta's shareholders are among the leading integrators of non-profit health care in America, sponsoring significant care providers in many parts of the country. Consorta's shareholder health care systems operate more than half of all Catholic hospitals in the United States, own many extended and alternate care sites and have extensive affiliate relationships with other non-profit hospitals and alternate care facilities.
About Elekta:
Elekta is a world-leading supplier of advanced and innovative radiation oncology and neurosurgery solutions and services for precise treatment of cancer and brain disorders. Elekta's solutions are clinically effective, cost efficient and gentle to the patient. For additional information about Elekta, please visit http://www.elekta.com/
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20020318/ELEKTALOGOPRN Photo Desk, photodesk@prnewswire.comElektaCONTACT: Michelle Lee, PR and Advertising Manager, +1-770-670-2447, ore-mail, michelle.lee@elekta.com, or Investor inquiries, United States, LarsJonsteg, VP Investor Relations North America, +1-770-670-2419, or e-mail,lars.jonsteg@elekta.com, or International, Peter Ejemyr, Group VP CorporateCommunications, +46 8 587 254 00, or e-mail, peter.ejemyr@elekta.com, all ofElekta
Web site: http://www.elekta.com/
